MarginsXMarginsX
Home › Markets › Health Care › IMNN

Imunon Inc. (IMNN)

IMNN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.5940
-5.56% on the day
Market cap
$3.9M
Nano cap
Revenue · 2022
$500K
0.0% on 2021
Net income · 2022
-$35.9M
-7179.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2022-12-31, https://www.sec.gov/Archives/edgar/data/749647/000149315224011616/0001493152-24-011616-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2022-12-31.

Profile

FieldValue
TickerIMNN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000749647
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2022

LineValue
Revenue$500K
Net income-$35.9M
Operating income-$24.9M
Net margin-7179.6%
Operating margin-4984.3%
Revenue growth0.0%
Cash$11.5M
Total assets$44.0M
P/E (computed)Net income was not positive
P/S (computed)7.7×

Warning signs

Cash runway
3.5 months
$4.0M cash at September 30, 2026
Share count, 1 year
+111.3%
2025-11-10 to 2026-11-12 · +800.2% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
-$38K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Such conditions raise substantial doubts about the Company's ability to continue as a going concern."
10-Q 2026-11-12
Cash and burn$4.0M cash; operating cash flow -$3.5M a quarter.Report 2026-09-30
Shares outstanding6,487,286 (2026-11-12); 3,070,354 a year earlier; 9,399,289 three years earlier. 3y figure adjusted for splits (1-for-13.043 overall).Cover page 2026-11-12
Reverse splits, 3 years1; latest 1-for-15 on 2025-07-25Source 2025-07-25
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-03-23
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWithumSmith+Brown, PC, East Brunswick, New Jersey, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $38K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$3.8M-$3.2M$4.0M$1.3MNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$2.8M-$3.0M$6.9M$1.5MNeeds four quarters10-Q 2026-08-11
Q1 2026
2026-03-31
Not filed-$4.2M-$4.0M$4.8MNo debt tagsNeeds four quarters10-Q 2026-05-12
Q4 2025
2025-12-31
Not filed-$4.2M-$3.7M$8.8MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$3.4M-$4.4M$5.3MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$2.7M-$3.0M$4.7MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q1 2025
2025-03-31
Not filed-$4.1M-$2.8M$2.9MNo debt tagsNeeds four quarters10-Q 2026-05-12
Q4 2024
2024-12-31
Not filed-$4.1M-$4.4M$5.9MNo debt tagsNeeds four quarters10-K 2026-03-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-1/A2026-10-28
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-05-04

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-25.0%
1 month-41.1%
3 months-60.1%
Year to date-83.5%
1 year-84.9%
From 52-week high-85.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
GELSGelteq Limited$0.3589-5.63%$3.8M
AZTRAzitra Inc$0.6270+3.06%$3.8M
XTLBXTL Biopharmaceuticals Ltd.$1.54-3.75%$3.8M
TRAWTraws Pharma Inc.$0.2600+3.59%$4.0M
XBIOXenetic Biosciences Inc.$1.49-10.24%$3.5M
BGMSBio Green Med Solution Inc.$0.6502+1.55%$4.3M
KPRXKiora Pharmaceuticals Inc.$0.9820-20.16%$4.3M
SILOSilo Pharma Inc.$1.57-14.40%$3.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier